Tirzepatide is a dual agonist - it activates both the GLP-1 receptor and the GIP receptor. Both are incretin hormones released by the gut after eating, and acting on the two together produces effects larger than acting on GLP-1 alone. In trials it has produced the greatest reductions in HbA1c and in body weight yet achieved by a medicine, and it is licensed for type 2 diabetes and, under a separate brand, for weight management.
Follow the plan your prescriber gave you. This guide contains no doses.
What the trials found
In type 2 diabetes, tirzepatide lowered HbA1c more than semaglutide in a head-to-head trial, with greater weight loss alongside.
In obesity without diabetes, average weight loss over about eighteen months reached figures approaching what some bariatric surgery achieves - considerably more than any previous medicine.
It has also shown benefit in obstructive sleep apnoea in people with obesity, and in heart failure with preserved ejection fraction.
See semaglutide, including what the withdrawal studies found about stopping.
Weight returns after stopping
As with the whole class, withdrawal studies show a large proportion of lost weight returns within about a year of stopping, and the metabolic improvements reverse with it.
That is not a failure of willpower - it is what happens when treatment for a chronic relapsing condition is removed, as it is when a blood pressure tablet stops.
The honest framing is long-term treatment rather than a course, and that should be clear before starting.
The contraception interaction
This is the one most likely to catch people out and the least expected.
Tirzepatide markedly slows gastric emptying, particularly after the first dose and after each increase, which reduces absorption of oral contraceptives.
Advice is to use an additional non-hormonal method, or switch to a non-oral hormonal method, for four weeks after starting and for four weeks after each dose increase.
Methods unaffected include the implant, the coil and the injection - see the contraceptive implant and desogestrel.
Tirzepatide is not used in pregnancy and should be stopped well before conception - which makes reliable contraception more rather than less important.
Build up slowly
Nausea, vomiting, diarrhoea and constipation are very common, worst after each dose increase and usually settling.
The dose is increased in steps over months for that reason. Rushing it is the main reason people abandon treatment.
Smaller portions, stopping when full, avoiding fatty and very sweet food, and not lying down after eating all help. If a step is intolerable, staying at the current dose longer is the standard answer.
What to report
Seek medical advice for severe, persistent abdominal pain radiating to the back, with or without vomiting - pancreatitis needs assessing and the drug stopping.
Report pain in the upper right abdomen after fatty meals, or jaundice - gallstones are more common with rapid weight loss and with this class.
Report any change in vision. Rapid improvement in glucose control can temporarily worsen diabetic retinopathy, so people with existing eye disease need monitoring.
Hypoglycaemia
Tirzepatide does not cause hypoglycaemia on its own. Combined with insulin or a sulfonylurea it can, and those doses are often reduced when it is started - see glimepiride.
Who should not take it
People with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. Anyone with a history of pancreatitis needs careful consideration.
Caution with significant gastroparesis or severe gastrointestinal disease.
Tell your anaesthetist before any procedure involving sedation - delayed stomach emptying affects fasting requirements, and guidance now addresses this after cases of aspiration.
Muscle as well as fat
Weight loss of this magnitude includes muscle. Adequate protein intake and resistance exercise matter considerably, particularly in older people, and this is an active area of research.
See medicines and your weight.
Counterfeits and unlicensed supply
Demand has far outstripped supply, and falsified pens have been seized in the UK - some containing insulin, with people hospitalised as a result.
Compounded or unlicensed versions sold online are a related problem, with no assurance of content or sterility.
Buy only through a registered pharmacy with a prescription from someone who has assessed you. A site with stock when legitimate pharmacies have none is telling you something.
See weight loss injections bought online and checking an online pharmacy is legitimate.
Practical points
Injected once weekly on the same day, into the abdomen, thigh or upper arm, rotating sites. The day can be changed if at least three days separate doses.
Unopened pens go in the fridge; in use they can be kept at room temperature for a limited period. Never freeze.
Used pens go in a sharps bin - see needles and sharps disposal.
Insulin Detemir: A Twice-Daily Background Insulin covers a related point, and the Conditions section has the rest of these guides.